Back to search

Article

Transcriptomic Deconvolution Reveals Prognostic Immune Signatures and Immunotherapy-Responsive Subtypes in Male Breast Cancer

2025-10-27

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Male breast cancer (MBC) is a rare malignancy with distinct biological and clinical features compared to its female counterpart. Emerging evidence suggests that a subset of MBCs may exhibit an immunogenic tumor microenvironment; however, the lack of sex-specific data on immune biomarkers has limited the inclusion of male patients in immunotherapy trials. <bo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f0e27345-38ed-544c-9431-60c31e9a8bc0
DOI
10.21203/rs.3.rs-7572724/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Transcriptomic Deconvolution Reveals Prognostic Immune Signatures and Immunotherapy-Responsive Subtypes in Male Breast CancerDOI 10.21203/rs.3.rs-7572724/v1
Select a neighboring publication to make it the new centre.